JD

Joel Dudley

Partner at Innovation Endeavors

Louisville, Colorado

Overview 

Joel Dudley is a Partner at Innovation Endeavors, investing in BioTech companies at Series A and Seed stages. With a Ph.D. from Stanford University, he has held key roles at prestigious institutions like Icahn School of Medicine at Mount Sinai and has been involved in successful ventures such as Onegevity Health. Dudley has a strong background in genomics, informatics, and bioinformatics, and has made impactful contributions to the field of healthcare through roles such as Chief Scientific Officer at Tempus Labs, Inc. and as a Co-Founder of Onegevity Health.

Work Experience 

  • Partner

    2022 - Current

Innovation Endeavors invests in visionary founders, transformational technology, and emergent ecosystems for a new world.

  • Investor, Board Member

    2022

  • Investor, Board Member

    2022

Harmonic Discovery operates as a pharmaceutical company that develops a platform that combines computing and experimentation.

Raised $8,000,000.00 from Innovation Endeavors, Fifty Years, Caffeinated Capital, Y Combinator and Boom Capital Ventures.

  • Investor, Board Member

    2022

  • Scientific Advisor

    2021

  • Associate Professor of Genetics and Genomic Sciences (w/ Tenure)

    2016

  • Endowed Chair of Biomedical Data Science

    2017 - 2019

  • Director of the Institute for Next Generation Healthcare

    2016 - 2019

  • Director of Biomedical Informatics

    2012 - 2019

  • Assistant Professor of Genetics and Genomic Sciences

    2012 - 2016

  • Chief Scientific Advisor

    2022 - 2023

  • Chief Scientific Officer

    2020 - 2022

    Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions and deliver personalized patient care. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com

  • Senior Vice President, Research

    2019 - 2020

  • Co-Founder and Scientific Advisor

    2018 - 2021

    Onegevity is a leading team of scientists and entrepreneurs with deep expertise in health, nutrition, molecular diagnostics, and artificial intelligence. Our mission is to empower individuals to find and maintain optimal health and wellness by democratizing access to actionable tools and information from leading-edge biomedical research. We develop products that customize scientific health and wellness innovations to fit individual characteristics and lifestyle so that you can stay unique and authentic in achieving your goals. Onegevity merged with Thorne in February of 2021 to create Thorne Health Tech (NASDAQ: THRN)

  • Executive Vice President for Precision Health

    2018 - 2019

Mount Sinai Health System delivers integrated medical care, research, and medical education through its network.

Raised $41,900,000.00 from National Institutes of Health, Hearst Health Prize., Multiple Myeloma Research Foundation, Steven & Alexandra Cohen Foundation and LifeSci NYC.

  • Scientific Advisor

    2015 - 2019

Articles About Joel

Relevant Websites